Clinical trial · Observational
Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors
Study About Contamination of Ovarian Tissue by RT-PCR in Children With Solid Tumors.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
For prepubertal patients, cryopreservation of ovarian tissue is the only option available to preserve their fertility before cancer treatment. But ovarian autograft raises the issue of the risk of reintroduction of potentially malignant cells. The aim of our study is to develop a specific and sensitive method for residual disease detection in the ovarian tissue from patients treated for a solid tumor during infancy, whose fertility may have been compromised by treatments and who benefited of ovarian tissue cryopreservation.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fertility Preservation | — | UNRESOLVED | — |
| Minimal Residual Disease | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| malignant cells | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- cryopreservation
- interventionNames
- Other: malignant cells
Primary outcomes (1)
- measure
- malignant cells about 1/10*6 cells.
- timeFrame
- at day 1
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Women of any age, diagnosed with a benign cyst that needs a laparoscopy may be included Exclusion Criteria: \-
References
Publications (0)
Data not yet available